Several composite scores (e.g., NAFLD Fibrosis score, NFS; Fibrosis-4, Fib-4; BMI-AST/ALT Ratio-Diabetes score, BARD) [11] have already been proposed to non-invasively identify AF, minimizing the need for liver biopsies in clinical practice [11]. The gene discussed is GPT; the disease is diabetes mellitus.